Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC34976105151;105152;105153 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
N2AB33335100228;100229;100230 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
N2A3240897447;97448;97449 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
N2B2591177956;77957;77958 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
Novex-12603678331;78332;78333 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
Novex-22610378532;78533;78534 chr2:178531689;178531688;178531687chr2:179396416;179396415;179396414
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAC
  • RefSeq wild type template codon: ATG
  • Domain: Ig-163
  • Domain position: 35
  • Structural Position: 49
  • Q(SASA): 0.1404
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/H None None 0.998 N 0.547 0.361 0.28297238246 gnomAD-4.0.0 1.5909E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43271E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.9663 likely_pathogenic 0.9851 pathogenic -2.734 Highly Destabilizing 0.927 D 0.577 neutral None None None None N
Y/C 0.6469 likely_pathogenic 0.8159 pathogenic -1.219 Destabilizing 0.999 D 0.605 neutral N 0.485739013 None None N
Y/D 0.9619 likely_pathogenic 0.9838 pathogenic -1.798 Destabilizing 0.998 D 0.631 neutral N 0.478737574 None None N
Y/E 0.9709 likely_pathogenic 0.9881 pathogenic -1.661 Destabilizing 0.999 D 0.609 neutral None None None None N
Y/F 0.0943 likely_benign 0.1283 benign -1.011 Destabilizing 0.068 N 0.203 neutral N 0.445375405 None None N
Y/G 0.954 likely_pathogenic 0.9723 pathogenic -3.085 Highly Destabilizing 0.984 D 0.615 neutral None None None None N
Y/H 0.5949 likely_pathogenic 0.7905 pathogenic -1.375 Destabilizing 0.998 D 0.547 neutral N 0.485232034 None None N
Y/I 0.8404 likely_pathogenic 0.9169 pathogenic -1.618 Destabilizing 0.864 D 0.542 neutral None None None None N
Y/K 0.9619 likely_pathogenic 0.9823 pathogenic -1.473 Destabilizing 0.984 D 0.617 neutral None None None None N
Y/L 0.785 likely_pathogenic 0.8559 pathogenic -1.618 Destabilizing 0.039 N 0.318 neutral None None None None N
Y/M 0.8607 likely_pathogenic 0.9149 pathogenic -1.267 Destabilizing 0.736 D 0.378 neutral None None None None N
Y/N 0.7878 likely_pathogenic 0.8925 pathogenic -1.885 Destabilizing 0.998 D 0.609 neutral N 0.496841829 None None N
Y/P 0.9989 likely_pathogenic 0.9995 pathogenic -1.993 Destabilizing 0.999 D 0.627 neutral None None None None N
Y/Q 0.9274 likely_pathogenic 0.9738 pathogenic -1.797 Destabilizing 0.995 D 0.587 neutral None None None None N
Y/R 0.9125 likely_pathogenic 0.9591 pathogenic -1.024 Destabilizing 0.995 D 0.603 neutral None None None None N
Y/S 0.8471 likely_pathogenic 0.9277 pathogenic -2.421 Highly Destabilizing 0.979 D 0.584 neutral N 0.499866037 None None N
Y/T 0.9328 likely_pathogenic 0.9666 pathogenic -2.189 Highly Destabilizing 0.984 D 0.59 neutral None None None None N
Y/V 0.8113 likely_pathogenic 0.8956 pathogenic -1.993 Destabilizing 0.864 D 0.532 neutral None None None None N
Y/W 0.5937 likely_pathogenic 0.7185 pathogenic -0.382 Destabilizing 0.999 D 0.558 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.